Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1993-11-4
|
| pubmed:abstractText |
Unasyn is a combination drug used for the treatment of infections as well as a prophylactic intervention prior to surgical or endoscopic interventions. Unasyn is a broad spectrum antibiotic of the penicillin family that inhibits beta-lactamases, ensuring activity of the ampicillin against resistant organisms. Peak serum levels of Unasyn are reached in 15 min to 1 hr after an IV infusion of 15 min.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
N
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
1042-895X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
16
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
36-8
|
| pubmed:dateRevised |
2005-11-17
|
| pubmed:meshHeading | |
| pubmed:year |
1993
|
| pubmed:articleTitle |
Unasyn (ampicillin sodium/sulbactam sodium).
|
| pubmed:publicationType |
Journal Article
|